메뉴 건너뛰기




Volumn 26, Issue 19, 2016, Pages 4739-4742

Discovery of novel 5-hydroxy-4-pyridone-3-carboxy acids as potent inhibitors of influenza Cap-dependent endonuclease

Author keywords

Anti influenza drug; Cap dependent endonuclease; Chelator; Pyridone; Virtual modeling

Indexed keywords

4 PYRIDONE DERIVATIVE; 5 HYDROXY 4 PYRIDONE 3 CARBOXY ACID DERIVATIVE; ANTIVIRUS AGENT; CAP DEPENDENT ENDONUCLEASE INHIBITOR; CHELATE; ESTERASE INHIBITOR; UNCLASSIFIED DRUG; 4-PYRIDONE; CARBOXYLIC ACID; ENDONUCLEASE; ENZYME INHIBITOR; PYRIDONE DERIVATIVE;

EID: 84985995054     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2016.08.038     Document Type: Article
Times cited : (14)

References (32)
  • 3
    • 69249232329 scopus 로고    scopus 로고
    • Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
    • 3 National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recommend Rep. 58, 2009, 1–8.
    • (2009) MMWR Recommend Rep. 58 , pp. 1-8
  • 4
    • 77958459368 scopus 로고    scopus 로고
    • WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses
    • World Health Organization Geneva, Switzerland
    • 4 World Health Organization, WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. 2010, World Health Organization, Geneva, Switzerland http://www.who.int/csr/resources/publications/swineflu/h1n1_guidelines_pharmaceutical_mngt.pdf.
    • (2010)
    • World Health Organization1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.